Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Anhui Fengyuan Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥69.15 Million ≈ $10.12 Million USD) by net assets (CN¥2.13 Billion ≈ $311.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Anhui Fengyuan Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Cash flow conversion efficiency of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. This chart illustrates how Anhui Fengyuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000153 share price today for real-time trading data and today's change.
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Anhui Fengyuan Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Anhui Fengyuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anhui Fengyuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review 000153 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Dynamic Power Co Ltd
SHG:600405
|
-29.336x |
|
Shandong Minhe Animal Husbandry Co Ltd
SHE:002234
|
0.026x |
|
Alexander Marine Co Ltd
TW:8478
|
0.024x |
|
Deutsche Beteiligungs AG
XETRA:DBAN
|
-0.020x |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
N/A |
|
Hunan Sokan New Materials Co. Ltd. A
SHG:688157
|
N/A |
|
Apogee Optocom Co Ltd
TW:6426
|
0.021x |
|
Integra Resources Corp
V:ITR
|
0.262x |
Annual Cash Flow Conversion Efficiency for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. Also see Anhui Fengyuan Pharmaceutical Co Ltd balance sheet assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.13 Billion ≈ $311.10 Million |
CN¥119.30 Million ≈ $17.46 Million |
0.056x | -9.06% |
| 2024-12-31 | CN¥2.05 Billion ≈ $299.38 Million |
CN¥126.24 Million ≈ $18.47 Million |
0.062x | -53.53% |
| 2023-12-31 | CN¥1.92 Billion ≈ $280.78 Million |
CN¥254.75 Million ≈ $37.28 Million |
0.133x | -47.05% |
| 2022-12-31 | CN¥1.75 Billion ≈ $256.78 Million |
CN¥439.99 Million ≈ $64.38 Million |
0.251x | +64.19% |
| 2021-12-31 | CN¥1.56 Billion ≈ $227.94 Million |
CN¥237.88 Million ≈ $34.81 Million |
0.153x | -24.47% |
| 2020-12-31 | CN¥1.45 Billion ≈ $211.88 Million |
CN¥292.75 Million ≈ $42.84 Million |
0.202x | +305.23% |
| 2019-12-31 | CN¥1.33 Billion ≈ $194.20 Million |
CN¥66.21 Million ≈ $9.69 Million |
0.050x | -72.41% |
| 2018-12-31 | CN¥1.29 Billion ≈ $189.03 Million |
CN¥233.59 Million ≈ $34.18 Million |
0.181x | +321.21% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.59 Million |
CN¥52.40 Million ≈ $7.67 Million |
0.043x | -36.72% |
| 2016-12-31 | CN¥1.15 Billion ≈ $168.69 Million |
CN¥78.21 Million ≈ $11.44 Million |
0.068x | +76.59% |
| 2015-12-31 | CN¥1.18 Billion ≈ $173.29 Million |
CN¥45.50 Million ≈ $6.66 Million |
0.038x | +319.25% |
| 2014-12-31 | CN¥1.15 Billion ≈ $167.83 Million |
CN¥10.51 Million ≈ $1.54 Million |
0.009x | +113.74% |
| 2013-12-31 | CN¥1.05 Billion ≈ $154.28 Million |
CN¥-70.31 Million ≈ $-10.29 Million |
-0.067x | -213.22% |
| 2012-12-31 | CN¥775.01 Million ≈ $113.41 Million |
CN¥45.65 Million ≈ $6.68 Million |
0.059x | -18.14% |
| 2011-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥55.06 Million ≈ $8.06 Million |
0.072x | -1.45% |
| 2010-12-31 | CN¥753.81 Million ≈ $110.31 Million |
CN¥55.04 Million ≈ $8.05 Million |
0.073x | +52.92% |
| 2009-12-31 | CN¥678.70 Million ≈ $99.31 Million |
CN¥32.41 Million ≈ $4.74 Million |
0.048x | -37.32% |
| 2008-12-31 | CN¥654.09 Million ≈ $95.71 Million |
CN¥49.82 Million ≈ $7.29 Million |
0.076x | -11.93% |
| 2007-12-31 | CN¥638.89 Million ≈ $93.49 Million |
CN¥55.26 Million ≈ $8.09 Million |
0.086x | +47.97% |
| 2006-12-31 | CN¥620.49 Million ≈ $90.80 Million |
CN¥36.27 Million ≈ $5.31 Million |
0.058x | +0.49% |
| 2005-12-31 | CN¥599.59 Million ≈ $87.74 Million |
CN¥34.88 Million ≈ $5.10 Million |
0.058x | +393.43% |
| 2004-12-31 | CN¥591.07 Million ≈ $86.49 Million |
CN¥-11.72 Million ≈ $-1.71 Million |
-0.020x | +0.35% |
| 2003-12-31 | CN¥576.00 Million ≈ $84.29 Million |
CN¥-11.46 Million ≈ $-1.68 Million |
-0.020x | -206.51% |
| 2002-12-31 | CN¥560.87 Million ≈ $82.07 Million |
CN¥10.48 Million ≈ $1.53 Million |
0.019x | -57.51% |
| 2001-12-31 | CN¥536.15 Million ≈ $78.46 Million |
CN¥23.57 Million ≈ $3.45 Million |
0.044x | -9.55% |
| 2000-12-31 | CN¥532.50 Million ≈ $77.92 Million |
CN¥25.88 Million ≈ $3.79 Million |
0.049x | +154.14% |
| 1999-12-31 | CN¥52.98 Million ≈ $7.75 Million |
CN¥1.01 Million ≈ $148.25K |
0.019x | -- |
About Anhui Fengyuan Pharmaceutical Co Ltd
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.